Rocket Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs f…

Biotechnology
US, Cranbury [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Rocket Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Rocket Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Rocket Pharmaceuticals, Inc..

End of RCKT's Analysis
CIK: 1281895 CUSIP: 77313F106 ISIN: US77313F1066 LEI: - UEI: -
Secondary Listings
RCKT has no secondary listings inside our databases.